These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32501643)

  • 1. Increased APOE glycosylation plays a key role in the atherogenicity of L5 low-density lipoprotein.
    Ke LY; Chan HC; Chen CC; Chang CF; Lu PL; Chu CS; Lai WT; Shin SJ; Liu FT; Chen CH
    FASEB J; 2020 Jul; 34(7):9802-9813. PubMed ID: 32501643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.
    Ke LY; Engler DA; Lu J; Matsunami RK; Chan HC; Wang GJ; Yang CY; Chang JG; Chen CH
    Pure Appl Chem; 2011; 83(9):. PubMed ID: 24198440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronegative Low-Density Lipoprotein L5 Induces Adipose Tissue Inflammation Associated With Metabolic Syndrome.
    Ke LY; Chan HC; Chan HC; Kalu FCU; Lee HC; Lin IL; Jhuo SJ; Lai WT; Tsao CR; Sawamura T; Dixon RA; Chen CH; Chu CS; Shin SJ
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4615-4625. PubMed ID: 29029093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of apolipoprotein E in electronegative low-density lipoprotein-induced mitochondrial dysfunction in cardiomyocytes.
    Chen WY; Chen YF; Chan HC; Chung CH; Peng HY; Ho YC; Chen CH; Chang KC; Tang CH; Lee AS
    Metabolism; 2020 Jun; 107():154227. PubMed ID: 32275974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitro.
    Chen WY; Chen FY; Lee AS; Ting KH; Chang CM; Hsu JF; Lee WS; Sheu JR; Chen CH; Shen MY
    J Nat Prod; 2015 Feb; 78(2):225-33. PubMed ID: 25692815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1.
    Tang D; Lu J; Walterscheid JP; Chen HH; Engler DA; Sawamura T; Chang PY; Safi HJ; Yang CY; Chen CH
    J Lipid Res; 2008 Jan; 49(1):33-47. PubMed ID: 17909223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction.
    Chang PY; Chen YJ; Chang FH; Lu J; Huang WH; Yang TC; Lee YT; Chang SF; Lu SC; Chen CH
    Cardiovasc Res; 2013 Jul; 99(1):137-45. PubMed ID: 23519265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The underlying chemistry of electronegative LDL's atherogenicity.
    Ke LY; Stancel N; Bair H; Chen CH
    Curr Atheroscler Rep; 2014 Aug; 16(8):428. PubMed ID: 24890631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronegative low-density lipoprotein induces cardiomyocyte apoptosis indirectly through endothelial cell-released chemokines.
    Lee AS; Wang GJ; Chan HC; Chen FY; Chang CM; Yang CY; Lee YT; Chang KC; Chen CH
    Apoptosis; 2012 Sep; 17(9):1009-18. PubMed ID: 22562555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronegative Low-Density Lipoprotein L5 Impairs Viability and NGF-Induced Neuronal Differentiation of PC12 Cells via LOX-1.
    Wang JY; Lai CL; Lee CT; Lin CY
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRP inhibits ox-LDL-induced endothelial cell apoptosis through an Akt-NF-{kappa}B-Bcl-2 pathway and inhibits endothelial cell apoptosis in an apoE-knockout mouse model.
    Liu S; Shen H; Xu M; Liu O; Zhao L; Liu S; Guo Z; Du J
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E351-63. PubMed ID: 20530739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
    Yang L; Gao C
    Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure and dynamics of a receptor-active apolipoprotein E peptide.
    Raussens V; Slupsky CM; Ryan RO; Sykes BD
    J Biol Chem; 2002 Aug; 277(32):29172-80. PubMed ID: 12036962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B and E basic amino acid clusters influence low-density lipoprotein association with lipoprotein lipase anchored to the subendothelial matrix.
    Saxena U; Auerbach BJ; Ferguson E; Wölle J; Marcel YL; Weisgraber KH; Hegele RA; Bisgaier CL
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1240-7. PubMed ID: 7627718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding.
    Kataoka H; Kume N; Miyamoto S; Minami M; Murase T; Sawamura T; Masaki T; Hashimoto N; Kita T
    J Biol Chem; 2000 Mar; 275(9):6573-9. PubMed ID: 10692464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290.
    Lee Y; Kockx M; Raftery MJ; Jessup W; Griffith R; Kritharides L
    Mol Cell Proteomics; 2010 Sep; 9(9):1968-81. PubMed ID: 20511397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
    Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonexchangeable apolipoprotein E peptide that mediates binding to the low density lipoprotein receptor.
    Mims MP; Darnule AT; Tovar RW; Pownall HJ; Sparrow DA; Sparrow JT; Via DP; Smith LC
    J Biol Chem; 1994 Aug; 269(32):20539-47. PubMed ID: 8051153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.